A detailed history of O'Shaughnessy Asset Management, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 20,450 shares of HRMY stock, worth $773,828. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,450
Previous 20,030 2.1%
Holding current value
$773,828
Previous $800,000 12.13%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$31.86 - $41.49 $13,381 - $17,425
420 Added 2.1%
20,450 $703,000
Q3 2024

Nov 12, 2024

BUY
$30.0 - $39.95 $23,730 - $31,600
791 Added 4.11%
20,030 $800,000
Q2 2024

Aug 14, 2024

BUY
$28.81 - $33.01 $554,275 - $635,079
19,239 New
19,239 $580,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.24B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.